Skip To Main Content

This website is intended exclusively for healthcare professionals residing and/or working in Qatar.

Campus

Login
Registration

Science
Acquired Thrombotic Thrombocytopenic Purpura (ATTP)
Asthma
Atopic Dermatitis
Chronic Obstructive Pulmonary Disease
Diabetes
Eosinophilic Esophagitis
Multiple Myeloma
Multiple Sclerosis
Nasal Polyps
Neurological Disorders
Prurigo Nodularis
Rare Diseases

Cardiovascular
Atherothrombosis
Dyslipidemia
Hypertension
Thrombosis

Vaccines
Influenza
RSV

Patient Support
Atopic Dermatitis
Cardiovascular
Diabetes
Nasal Polyps
Rare Diseases

Product
Adacel®
Cerezyme®
Lemtrada®
Myozyme®
Nexviazyme
Renvela®
Solian®
Tavanic®
Xatral®
Xenpozyme®

Aubagio®
Aubagio vs Ofatumumab

Cablivi®
aTTP Sphere Digital Case Library

Clexane®
Surgical Patients
Hemodialysis

Dupixent®
Prurigo Nodularis
Atopic Dermatitis
Dupixent® COPD

Fabrazyme®
Quantifying the Effect of Fabrazyme
Canadian Fabry Disease Initiative
Long Term Renal Function

Plavix®
Tolerability

Praluent®
Praluent 300 mg

Sarclisa®
Sarclisa®
Sarclisa KD®
Sarclisa PD®

Soliqua®
For a Peaceful Ramadan
Soli-Simplify Study
Soliqua SoliD®
Soliqua Easy Start®
Soliqua Guidelines®
Soliqua Data Set®
Soliqua Simplicity®
Soliqua Safety®
Soliqua®

Toujeo®
Toujeo for a Peaceful Ramadan
Wall of Evidence
How to Start
Time in Range

Toujeo T1DM
OneCare
Edition Junior
UltraFlexi-1
Type-1 Meta Analysis
Guidelines

Toujeo T2DM
Deliver-G
Guidelines

Toujeo Innovation
Toujeo Upgrade to Win

Zympass®
Tolerability
Usage

Campus

Science
Acquired Thrombotic Thrombocytopenic Purpura (ATTP)
Asthma
Atopic Dermatitis
Chronic Obstructive Pulmonary Disease
Diabetes
Eosinophilic Esophagitis
Multiple Myeloma
Multiple Sclerosis
Nasal Polyps
Neurological Disorders
Prurigo Nodularis
Rare Diseases

Cardiovascular
Atherothrombosis
Dyslipidemia
Hypertension
Thrombosis

Vaccines
Influenza
RSV

Patient Support
Atopic Dermatitis
Cardiovascular
Diabetes
Nasal Polyps
Rare Diseases

Product
Adacel®
Cerezyme®
Lemtrada®
Myozyme®
Nexviazyme
Renvela®
Solian®
Tavanic®
Xatral®
Xenpozyme®

Aubagio®
Aubagio vs Ofatumumab

Cablivi®
aTTP Sphere Digital Case Library

Clexane®
Surgical Patients
Hemodialysis

Dupixent®
Prurigo Nodularis
Atopic Dermatitis
Dupixent® COPD

Fabrazyme®
Quantifying the Effect of Fabrazyme
Canadian Fabry Disease Initiative
Long Term Renal Function

Plavix®
Tolerability

Praluent®
Praluent 300 mg

Sarclisa®
Sarclisa®
Sarclisa KD®
Sarclisa PD®

Soliqua®
For a Peaceful Ramadan
Soli-Simplify Study
Soliqua SoliD®
Soliqua Easy Start®
Soliqua Guidelines®
Soliqua Data Set®
Soliqua Simplicity®
Soliqua Safety®
Soliqua®

Toujeo®
Toujeo for a Peaceful Ramadan
Wall of Evidence
How to Start
Time in Range

Toujeo T1DM
OneCare
Edition Junior
UltraFlexi-1
Type-1 Meta Analysis
Guidelines

Toujeo T2DM
Deliver-G
Guidelines

Toujeo Innovation
Toujeo Upgrade to Win

Zympass®
Tolerability
Usage

Login
Registration

Home
Science
Neurological Disorders
Cutting Edge Science
2023
Epilepsy Do’s and Don’ts

Epilepsy Do’s and Don’ts

MAT-BH-2300335/V1/May 2023

Campus

Back to top

Legal notice Cookie policy Privacy Policy Sitemap Change country

© Sanofi 2004- - All rights reserved

MAT-QA-2100056/V8/MAR2024

SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE,

Tel.: +971 4 550 3600 | Fax: +971 4 5521050

For further medical information for all Gulf countries, please contact: +971 45 50 38 63
or email: medical-information.gulf@sanofi.com

To report an adverse event: please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com
To report any product technical complaints, kindly contact Email: quality.greatergulf@sanofi.com

leave-site-modal-text

You Will Now Be Leaving the Site

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.